George Perry to Glucagon-Like Peptides
This is a "connection" page, showing publications George Perry has written about Glucagon-Like Peptides.
Connection Strength
0.220
-
Associations of semaglutide with first-time diagnosis of Alzheimer's disease in patients with type 2 diabetes: Target trial emulation using nationwide real-world data in the US. Alzheimers Dement. 2024 Dec; 20(12):8661-8672.
Score: 0.220